Akero Therapeutics successfully completes pricing of stock offering
Wednesday, 6 March 2024, 08:34
Akero Therapeutics Prices Stock Offering to Raise $319M
Akero Therapeutics, a leading biotechnology company, has successfully completed the pricing of its stock offering to raise $319 million. This significant financial move is aimed at bolstering the company's financial standing and supporting its growth strategies in the biopharmaceutical sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.